Funding for this research was provided by:
Wellcome Trust (209583/Z/17/Z)
Khon Kaen University
University College London Hospitals NHS Foundation Trust
Article History
First Online: 22 August 2020
Compliance with Ethical Standards
:
: Emma Matthews received an honorarium from LUPIN pharmaceuticals for attending a scientific advisory meeting in 2018 (LUPIN pharmaceuticals manufactures Namuscla, the mexiletine preparation licenced for myotonia). Nantaporn Jitpimolmard declares that he has no conflicts of interest. Doreen Fialho declares that she has no conflicts of interest.